These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25230364)

  • 21. The pharmacoepigenetics of drug metabolism and transport in breast cancer: review of the literature and in silico analysis.
    Nasr R; Sleiman F; Awada Z; Zgheib NK
    Pharmacogenomics; 2016 Sep; 17(14):1573-85. PubMed ID: 27561648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic profiling joins personalized cancer medicine.
    Heyn H; Méndez-González J; Esteller M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic mechanisms underlying unanticipated drug responses.
    Carlquist JF; Anderson JL
    Discov Med; 2011 May; 11(60):469-78. PubMed ID: 21616045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacogenomics genomics approaches to optimizing drug therapy].
    Shi J; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):156-8. PubMed ID: 11941596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
    Yan Q
    Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
    Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized medicine and type 2 diabetes: lesson from epigenetics.
    Raciti GA; Nigro C; Longo M; Parrillo L; Miele C; Formisano P; Béguinot F
    Epigenomics; 2014 Apr; 6(2):229-38. PubMed ID: 24811791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
    Ozawa S
    Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors.
    Nakajima M; Yokoi T
    Pharmacol Ther; 2011 Sep; 131(3):330-7. PubMed ID: 21565218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical SNP detection by the SmartAmp method.
    Ishikawa T; Hayashizaki Y
    Methods Mol Biol; 2013; 1015():55-69. PubMed ID: 23824848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized medicine: going to the dogs?
    Mealey KL; Martinez SE; Villarino NF; Court MH
    Hum Genet; 2019 May; 138(5):467-481. PubMed ID: 31032534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA amplification techniques in pharmacogenomics.
    Morlighem JÉ; Harbers M; Traeger-Synodinos J; Lezhava A
    Pharmacogenomics; 2011 Jun; 12(6):845-60. PubMed ID: 21692615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers in the era of personalized medicine - a multiplexed SNP assay using capillary electrophoresis for assessing drug metabolism capacity.
    Rai AJ; Yee J; Fleisher M
    Scand J Clin Lab Invest Suppl; 2010; 242():15-8. PubMed ID: 20515270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC; Kacevska M; Ingelman-Sundberg M
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.
    Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J
    Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where are we today with personalized medicine?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.